Congestive Heart Failure Clinical Trial
Official title:
Corox OTW Steroid LV Lead Monitoring
The objective of this post approval registry is to confirm the long-term safety and
effectiveness of the Corox Over-the-wire (OTW) Steroid Left Ventricular (LV) lead as used in
conjunction with a BIOTRONK cardiac resynchronization therapy defibrillator (CRT-D). The
Corox OTW Steroid LV Lead is capable of providing permanent pacing therapy to the left
ventricle in a CRT-D system. The following are the specific objectives to be evaluated
during this post-approval registry:
- Long-term effectiveness of the COROX OTW Steroid in providing biventricular pacing
- Safety of the COROX OTW Steroid LV pacing lead
This post approval registry enrolled 221 patients from 34 centers. The collection of
registry data continued for three years for each enrolled subject. Potential patients were
screened by the enrolling physician according to the detailed inclusion and exclusion
criteria below.
The specific required visits for this registry are: Enrollment, Three-month, Six month,
One-year, Routine Follow-Ups (every subsequent 6 months), Interim follow-ups for Corox OTW
Steroid LV lead related visits, and Out of Service visit. Data will be collected at each
patient follow-up. The programmed pacing parameters, LV pacing impedance, and LV pacing
threshold measurement at 0.5ms pulse width will be obtained. The programming parameters will
be set to best suit each patient. If adequate system function, including effective CRT,
cannot be obtained, the patient should not be selected for the registry.
;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04115735 -
His Bundle Recording From Subclavian Vein
|
||
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT04037436 -
Functional Exercise and Nutrition Education Program for Older Adults
|
N/A | |
Recruiting |
NCT04703842 -
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
|
Phase 1/Phase 2 | |
Terminated |
NCT05594940 -
Heart Failure Monitoring With a Portable Ultrasound Device With Artificial Intelligence Assisted Tools: A Multi-Phase Observational Feasibility Study
|
||
Recruiting |
NCT04982081 -
Treating Congestive HF With hiPSC-CMs Through Endocardial Injection
|
Phase 1 | |
Completed |
NCT04394754 -
Evaluating Efficacy of Digital Health Technology in the Treatment of Congestive Heart Failure
|
N/A | |
Active, not recruiting |
NCT01385176 -
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
|
N/A | |
Not yet recruiting |
NCT05516290 -
Evaluating Clinical Trial Experiences of Individuals With Congestive Heart Failure
|
||
Completed |
NCT02885636 -
Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial
|
Phase 3 | |
Terminated |
NCT02788656 -
Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)
|
Phase 4 | |
Completed |
NCT02252757 -
Assess Measurements of Wireless Cardiac Output Device
|
N/A | |
Terminated |
NCT02205411 -
Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
|
N/A | |
Completed |
NCT01362855 -
Advance Care Planning Evaluation in Hospitalized Elderly Patients
|
||
Withdrawn |
NCT00346177 -
Stem Cell Study for Patients With Heart Failure
|
Phase 2 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Active, not recruiting |
NCT01058837 -
SCD-HeFT 10 Year Follow-up
|
N/A | |
Completed |
NCT00957541 -
Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device
|
Phase 2 |